 |
BioWorld-International-2005-12-14
BioAlliance Pharma Completes Initial Public Offering For EUR30M
BioAlliance Pharma Completes Initial Public Offering For EUR30M
PARIS - BioAlliance Pharma SA completed its initial public offering on Eurolist Compartment C of the Euronext stock exchange in Paris, raising gross proceeds of some €30 million (US$35.9 million). (BioWorld International)